Prakash Ramachandran

8.3k total citations · 4 hit papers
41 papers, 4.3k citations indexed

About

Prakash Ramachandran is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Prakash Ramachandran has authored 41 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 19 papers in Epidemiology and 11 papers in Immunology. Recurrent topics in Prakash Ramachandran's work include Liver Disease Diagnosis and Treatment (16 papers), Liver physiology and pathology (15 papers) and Phagocytosis and Immune Regulation (6 papers). Prakash Ramachandran is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Liver physiology and pathology (15 papers) and Phagocytosis and Immune Regulation (6 papers). Prakash Ramachandran collaborates with scholars based in United Kingdom, United States and Netherlands. Prakash Ramachandran's co-authors include John P. Iredale, Antonella Pellicoro, Jonathan Fallowfield, Stuart J. Forbes, Nico van Rooijen, Luke Boulter, Stephen N. Hartland, Neil C. Henderson, Timothy T. Gordon‐Walker and Rebecca L. Aucott and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Prakash Ramachandran

38 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liver fibrosis and repair: immune regulation of wound healing in a solid organ

2014 1.0k citations Antonella Pellicoro, Prakash Ramachandran et al. profile →
Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis

2012 757 citations Prakash Ramachandran, Antonella Pellicoro et al. Proceedings of the National Academy of Sciences profile →
Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease

2012 582 citations Luke Boulter, Prakash Ramachandran et al. Nature Medicine profile →
Immunology of human fibrosis

2023 71 citations Mallar Bhattacharya, Prakash Ramachandran Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Prakash Ramachandran United Kingdom	22	2.1k	1.8k	1.1k	1.1k	880	41	4.3k
Antonella Pellicoro United Kingdom	14	1.7k 0.8×	1.4k 0.8×	891 0.8×	721 0.7×	822 0.9×	21	3.6k
David Scholten Germany	16	1.5k 0.7×	1.4k 0.8×	608 0.6×	444 0.4×	507 0.6×	24	2.8k
Peter Huebener Germany	14	916 0.4×	876 0.5×	761 0.7×	538 0.5×	555 0.6×	24	2.7k
Robert A. DeAngelis United States	24	1.4k 0.7×	1.1k 0.6×	918 0.9×	1.8k 1.7×	857 1.0×	37	4.2k
Mihael Vucur Germany	28	887 0.4×	1.4k 0.8×	1.8k 1.7×	664 0.6×	585 0.7×	74	3.8k
Thomas Knittel Germany	33	2.0k 1.0×	1.3k 0.8×	1.0k 1.0×	354 0.3×	792 0.9×	61	3.2k
Bernhard Saile Germany	29	1.7k 0.8×	1.2k 0.7×	725 0.7×	255 0.2×	671 0.8×	57	2.7k
Steve S. Choi United States	42	3.1k 1.5×	3.2k 1.8×	2.5k 2.3×	405 0.4×	1.6k 1.9×	68	6.5k
Tu Vinh Luong United Kingdom	31	1.4k 0.7×	1.8k 1.0×	499 0.5×	514 0.5×	1.1k 1.2×	113	3.9k
Minoru Tanabe Japan	35	1.7k 0.8×	949 0.5×	963 0.9×	399 0.4×	2.4k 2.7×	274	5.1k

Countries citing papers authored by Prakash Ramachandran

Since Specialization

Citations

This map shows the geographic impact of Prakash Ramachandran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prakash Ramachandran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prakash Ramachandran more than expected).

Fields of papers citing papers by Prakash Ramachandran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prakash Ramachandran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prakash Ramachandran. The network helps show where Prakash Ramachandran may publish in the future.

Co-authorship network of co-authors of Prakash Ramachandran

This figure shows the co-authorship network connecting the top 25 collaborators of Prakash Ramachandran. A scholar is included among the top collaborators of Prakash Ramachandran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prakash Ramachandran. Prakash Ramachandran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Henderson, Neil C., et al.. (2025). Dissecting the mechanisms of MASLD fibrosis in the era of single-cell and spatial omics. Journal of Clinical Investigation. 135(18). 1 indexed citations

Ramachandran, Prakash. (2025). Unpicking the senescence paradox in MASLD-associated HCC. Journal of Hepatology. 82(6). 1133–1134.

Ramachandran, Prakash, Madara Brice, Anna M. Hoy, et al.. (2024). Aberrant basement membrane production by HSCs in MASLD is attenuated by the bile acid analog INT-767. Hepatology Communications. 8(12). 1 indexed citations

Ramachandran, Prakash, et al.. (2024). Implications of innate immune sexual dimorphism for MASLD pathogenesis and treatment. Trends in Pharmacological Sciences. 45(7). 614–627. 13 indexed citations

Bhattacharya, Mallar & Prakash Ramachandran. (2023). Immunology of human fibrosis. Nature Immunology. 24(9). 1423–1433. 71 indexed citations breakdown →

Kendall, Timothy J., Frances Turner, Prakash Ramachandran, et al.. (2023). An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease. Nature Medicine. 29(11). 2939–2953. 35 indexed citations

Ramachandran, Prakash, et al.. (2022). Macrophages as key regulators of liver health and disease. International review of cell and molecular biology. 368. 143–212. 29 indexed citations

Dobie, Ross, Beth E. P. Henderson, John R. Wilson‐Kanamori, et al.. (2021). Deciphering Mesenchymal Drivers of Human Dupuytren’s Disease at Single-Cell Level. Journal of Investigative Dermatology. 142(1). 114–123.e8. 14 indexed citations

Pinto, Marlène Magalhaes, P. M. Smith, Jordan R. Portman, et al.. (2021). Role of Tim4 in the regulation of ABCA1+ adipose tissue macrophages and post-prandial cholesterol levels. Nature Communications. 12(1). 4434–4434. 29 indexed citations

10.

Conway, Bryan R., Eoin O’Sullivan, Carolynn Cairns, et al.. (2020). Kidney Single-Cell Atlas Reveals Myeloid Heterogeneity in Progression and Regression of Kidney Disease. Journal of the American Society of Nephrology. 31(12). 2833–2854. 130 indexed citations

11.

Gossner, Anton, Prakash Ramachandran, Joana Alves, et al.. (2020). Single-cell RNA-seq reveals CD16- monocytes as key regulators of human monocyte transcriptional response to Toxoplasma. Scientific Reports. 10(1). 21047–21047. 8 indexed citations

12.

King, Andrew, Diarmaid D. Houlihan, Dean Kavanagh, et al.. (2017). Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis. Gastroenterology. 153(1). 233–248.e16. 48 indexed citations

13.

Ramachandran, Prakash & Neil C. Henderson. (2016). Antifibrotics in chronic liver disease: tractable targets and translational challenges. The Lancet. Gastroenterology & hepatology. 1(4). 328–340. 37 indexed citations

14.

Bailey, L. Charles, et al.. (2014). PWE-136 Hepatocellular Cancer Detected In The Cirrhosis Surveillance Programme Have Better Outcomes Than Those Diagnosed Symptomatically. Gut. 63(Suppl 1). A184.2–A184. 1 indexed citations

15.

Snowdon, Victoria, Antonella Pellicoro, Prakash Ramachandran, et al.. (2013). PWE-146 Relaxin Is a Renal Vasodilator in Experimental Models of Cirrhosis and A Potential Novel Therapy for Hepatorenal Syndrome in Humans. Gut. 62(Suppl 1). A190.3–A191.

16.

Ramachandran, Prakash, Antonella Pellicoro, Madeleine A. Vernon, et al.. (2012). Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proceedings of the National Academy of Sciences. 109(46). E3186–95. 757 indexed citations breakdown →

17.

Ramachandran, Prakash & John P. Iredale. (2012). Liver fibrosis: a bidirectional model of fibrogenesis and resolution. QJM. 105(9). 813–817. 85 indexed citations

18.

Gibbons, Michael, Alison C. MacKinnon, Prakash Ramachandran, et al.. (2011). Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis. American Journal of Respiratory and Critical Care Medicine. 184(5). 569–581. 363 indexed citations

19.

Thomas, James A., Caroline Pope, Davina Wojtacha, et al.. (2011). Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology. 53(6). 2003–2015. 280 indexed citations

20.

Pellicoro, Antonella, Rebecca L. Aucott, Prakash Ramachandran, et al.. (2011). Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis. Hepatology. 55(6). 1965–1975. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact